ProQR (PRQR - Research Report) received a Hold rating and price target from JMP Securities analyst Jonathan Wolleben today. The company's shares...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K &nbs...
In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on ProQR (PRQR β Research Report), with a price target of...
In a report released today, Keay Nakae from Chardan Capital reiterated a Buy rating on ProQR (PRQR β Research Report), with a price target of...
In a report released today, Jonathan Wolleben from JMP Securities reiterated a Buy rating on ProQR (PRQR β Research Report), with a price target...
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 6-KReport of Foreign Private...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K  ...
In a report issued on May 7, Dae Gon Ha from Stifel Nicolaus maintained a Hold rating on ProQR (PRQR β Research Report), with a price target of...
0.960.931.380.960.931.38ProQR Therapeutics N.V.00016129402021FYfalse12600004150001210000001612940prqr:RvoInnovat...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads